Chief Executive Officer
Ken Shultis is Managing Partner, Rondaxe Pharma. He began working with Rondaxe Pharma in 2006 and became Managing Partner in 2007. He has more than 35 years of experience in pharmaceutical process development and manufacturing. He started his career at Abbott Laboratories in fermentation development and went on to work for Merck & Co., Inc., and Bristol-Myers Squibb. He then started American Advanced Organics, a custom fine-chemicals company that he sold to AMRI and became General Manager of Manufacturing. He rejoined his former colleagues from Bristol-Myers Squibb in the recently established Rondaxe Pharma consultancy where he has led the Rondaxe software products effort. He holds a BSChE from the University of Wisconsin and an MSChE from the University of Minnesota.